ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

PGIM INDIA HEALTHCARE FUND

PGIM PGIM India Mutual Fund May 2025 — Sep 2026 17 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹124 CrAt NSE closes, Sep 2026
Companies held3131 with an NSE price
Top 10 holdings60.3%Of the equity shown here
Largest holding10.9%Divi's Laboratories Limited
12-month turnover40.1%Estimated from 11 monthly disclosures · compare

Days to sell half: 0.4 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

17 priced months, May 2025 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

60.3% now, 62.4% in Sep 2025 · highest 69.0%, lowest 60.3%

Companies held

31 now, 30 in Sep 2025 · largest single holding 10.9% of equity

How it trades: no clear lean toward recent winners or losers (score +0.11 over 8 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 22 shared56.1%
  2. Mirae Asset Healthcare FundMirae Asset · 17 shared55.0%
  3. HDFC Pharma and Healthcare FundHDFC · 19 shared54.6%
  4. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 21 shared53.8%
  5. ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 17 shared51.4%
  6. EODWHFEdelweiss · 15 shared51.0%
  7. Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 16 shared50.9%
  8. SBI Healthcare Opportunities FundSBI · 17 shared50.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 2 Companies added
Complete exits 2 Companies sold out
Increases 16 More shares than last month
Reductions 1 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Divi's Laboratories Limited Healthcare Large Cap 10.92% 13.50 Cr 14,529 by May 2025 (17 mo+)
Sun Pharmaceutical Industries Limited Healthcare Large Cap 10.80% 13.35 Cr 73,508 by May 2025 (17 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 8.95% 11.06 Cr 23,046 by May 2025 (17 mo+)
Ajanta Pharma Limited Healthcare Small Cap 5.23% 6.46 Cr 17,855 by May 2025 (17 mo+)
Max Healthcare Institute Limited Healthcare Large Cap 4.97% 6.14 Cr 66,054 by May 2025 (17 mo+)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 4.56% 5.64 Cr 28,402 by May 2025 (17 mo+)
Mankind Pharma Limited Healthcare Mid Cap 4.26% 5.27 Cr 21,045 by May 2025 (17 mo+)
Manipal Health Enterprises Limited Not classified — 3.87% 4.79 Cr 67,646 Jul 2026 (3 mo)
Navin Fluorine International Limited Chemicals Small Cap 3.42% 4.22 Cr 5,122 by May 2025 (17 mo+)
Abbott India Limited Healthcare Mid Cap 3.29% 4.06 Cr 1,498 by May 2025 (17 mo+)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 3.15% 3.90 Cr 52,247 by May 2025 (17 mo+)
Rubicon Research Limited Healthcare Small Cap 3.15% 3.90 Cr 24,070 Oct 2025 (12 mo)
Neuland Laboratories Limited Healthcare Small Cap 3.06% 3.79 Cr 1,774 by May 2025 (17 mo+)
Aster DM Quality Care Limited Healthcare Small Cap 2.70% 3.34 Cr 47,891 by May 2025 (17 mo+)
Sai Life Sciences Limited Healthcare Small Cap 2.68% 3.32 Cr 21,756 by May 2025 (17 mo+)
ICICI Lombard General Insurance Company Limited Financial Services Mid Cap 2.21% 2.74 Cr 17,223 by May 2025 (17 mo+)
Cipla Limited Healthcare Large Cap 2.15% 2.66 Cr 19,771 by May 2025 (17 mo+)
Zydus Lifesciences Limited Healthcare Mid Cap 2.15% 2.66 Cr 22,885 Jun 2026 (4 mo)
Lupin Limited Healthcare Mid Cap 2.04% 2.52 Cr 12,400 Apr 2026 (6 mo)
IPCA Laboratories Limited Healthcare Mid Cap 2.02% 2.50 Cr 12,990 Aug 2026 (2 mo)
Dr Agarwals Eye Hospital Limited Not classified Small Cap 1.96% 2.42 Cr 4,726 by May 2025 (17 mo+)
Anthem Biosciences Limited Healthcare Mid Cap 1.91% 2.36 Cr 27,457 Jul 2025 (15 mo)
Global Health Limited Healthcare Mid Cap 1.61% 1.99 Cr 14,551 by May 2025 (17 mo+)
Gland Pharma Limited Healthcare Small Cap 1.58% 1.95 Cr 6,725 Aug 2026 (2 mo)
Jupiter Life Line Hospitals Limited Not classified Small Cap 1.54% 1.90 Cr 74,950 by May 2025 (17 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 1.53% 1.90 Cr 24,640 Apr 2026 (6 mo)
Symbiotec Pharmalab Limited Not classified — 1.16% 1.43 Cr 12,158 Sep 2026 (1 mo)
Lenskart Solutions Limited Consumer Services Mid Cap 1.04% 1.28 Cr 18,751 Oct 2025 (12 mo)
Molbio Diagnostics Limited Not classified — 0.84% 1.04 Cr 7,977 Sep 2026 (1 mo)
Orchid Pharma Limited Not classified Small Cap 0.83% 1.03 Cr 10,285 by May 2025 (17 mo+)
SAGILITY LIMITED Information Technology Small Cap 0.42% 0.52 Cr 0.01 Cr by May 2025 (17 mo+)

Half of its current holdings have been held for 17 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Dr. Agarwal's Health Care Limited Sep 2026 ▼ Complete exit -20,940
Symbiotec Pharmalab Limited Sep 2026 ▲ New position +12,158
IPCA Laboratories Limited Sep 2026 ▲ Increasing +9,780
Fortis Healthcare Limited Sep 2026 ▲ Increasing +9,480
Molbio Diagnostics Limited Sep 2026 ▲ New position +7,977
Zydus Lifesciences Limited Sep 2026 ▲ Increasing +6,630
Max Healthcare Institute Limited Sep 2026 ▲ Increasing +6,490
ICICI Lombard General Insurance Company Limited Sep 2026 ▲ Increasing +6,060
Sun Pharmaceutical Industries Limited Sep 2026 ▲ Increasing +5,820
Pfizer Limited Sep 2026 ▼ Complete exit -5,665
Lenskart Solutions Limited Sep 2026 ▲ Increasing +5,250
Lupin Limited Sep 2026 ▲ Increasing +4,280
Gland Pharma Limited Sep 2026 ▲ Increasing +3,550
Rubicon Research Limited Sep 2026 ▼ Reducing -3,520
Dr. Lal Path Labs Ltd. Sep 2026 ▲ Increasing +2,970
Dr Agarwals Eye Hospital Limited Sep 2026 ▲ Increasing +1,882
Torrent Pharmaceuticals Limited Sep 2026 ▲ Increasing +1,160
Ajanta Pharma Limited Sep 2026 ▲ Increasing +1,090
Navin Fluorine International Limited Sep 2026 ▲ Increasing +730
Divi's Laboratories Limited Sep 2026 ▲ Increasing +190
Abbott India Limited Sep 2026 ▲ Increasing +130
Manipal Health Enterprises Limited Aug 2026 ▲ Increasing +49,396
Aster DM Quality Care Limited Aug 2026 ▼ Reducing -36,488
Sun Pharmaceutical Industries Limited Aug 2026 ▲ Increasing +6,790
ICICI Lombard General Insurance Company Limited Aug 2026 ▲ Increasing +5,045
IPCA Laboratories Limited Aug 2026 ▲ New position +3,210
Gland Pharma Limited Aug 2026 ▲ New position +3,175
Zydus Lifesciences Limited Aug 2026 ▲ Increasing +2,900
Lupin Limited Aug 2026 ▲ Increasing +2,430
Dr Agarwals Eye Hospital Limited Aug 2026 ▲ Increasing +1,850
Dr. Lal Path Labs Ltd. Aug 2026 ▲ Increasing +1,700
Cipla Limited Aug 2026 ▲ Increasing +1,660
Torrent Pharmaceuticals Limited Aug 2026 ▲ Increasing +1,446
Pfizer Limited Aug 2026 ▲ Increasing +450
Navin Fluorine International Limited Aug 2026 ▲ Increasing +240
Abbott India Limited Aug 2026 ▲ Increasing +70
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -28,785
Dr. Reddy's Laboratories Limited Jul 2026 ▼ Complete exit -20,021
Manipal Health Enterprises Limited Jul 2026 ▲ New position +18,250
Torrent Pharmaceuticals Limited Jul 2026 ▲ Increasing +14,680
Dr. Lal Path Labs Ltd. Jul 2026 ▲ Increasing +4,312
Rubicon Research Limited Jul 2026 ▼ Reducing -1,780
Pfizer Limited Jul 2026 ▲ Increasing +1,367
Sun Pharmaceutical Industries Limited Jul 2026 ▲ Increasing +710
Abbott India Limited Jul 2026 ▲ Increasing +260
Rubicon Research Limited Jun 2026 ▼ Reducing -27,310
Zydus Lifesciences Limited Jun 2026 ▲ New position +13,355
Max Healthcare Institute Limited Jun 2026 ▲ Increasing +10,363
PB Fintech Limited Jun 2026 ▼ Complete exit -7,678
Cipla Limited Jun 2026 ▲ Increasing +6,989
Ajanta Pharma Limited Jun 2026 ▲ Increasing +1,505
Pfizer Limited Jun 2026 ▲ Increasing +1,108
Fortis Healthcare Limited Apr 2026 ▲ New position +15,160
Aster DM Quality Care Limited Apr 2026 ▼ Reducing -11,110
Dr. Reddy's Laboratories Limited Apr 2026 ▼ Reducing -6,760
Lupin Limited Apr 2026 ▲ New position +5,690
Rubicon Research Limited Apr 2026 ▼ Reducing -3,280
Pfizer Limited Apr 2026 ▲ Increasing +1,035
SAGILITY LIMITED Mar 2026 ▼ Reducing -31,050
Dr. Reddy's Laboratories Limited Mar 2026 ▼ Reducing -16,990
Dr. Agarwal's Health Care Limited Mar 2026 ▲ Increasing +11,440
Sai Life Sciences Limited Mar 2026 ▼ Reducing -5,880
Aster DM Quality Care Limited Mar 2026 ▼ Reducing -4,350
Rubicon Research Limited Mar 2026 ▼ Reducing -2,760
Sun Pharmaceutical Industries Limited Mar 2026 ▼ Reducing -2,010
Krishna Institute of Medical Sciences Limited Mar 2026 ▼ Reducing -1,740
Pfizer Limited Mar 2026 ▲ New position +1,705
Global Health Limited Mar 2026 ▼ Reducing -1,300
Torrent Pharmaceuticals Limited Mar 2026 ▼ Reducing -1,000
Dr. Lal Path Labs Ltd. Mar 2026 ▲ Increasing +730
PB Fintech Limited Mar 2026 ▼ Reducing -630
Divi's Laboratories Limited Mar 2026 ▼ Reducing -580
Jupiter Life Line Hospitals Limited Mar 2026 ▼ Reducing -530
Mankind Pharma Limited Mar 2026 ▲ Increasing +450
Neuland Laboratories Limited Mar 2026 ▲ Increasing +200
Abbott India Limited Mar 2026 ▼ Reducing -70
SAGILITY LIMITED Feb 2026 ▼ Reducing -85,740
PB Fintech Limited Feb 2026 ▼ Reducing -3,741
Lenskart Solutions Limited Feb 2026 ▼ Reducing -3,470
Dr. Reddy's Laboratories Limited Feb 2026 ▼ Reducing -2,360
Global Health Limited Feb 2026 ▼ Reducing -2,220
Sai Life Sciences Limited Feb 2026 ▼ Reducing -2,100
Rubicon Research Limited Feb 2026 ▼ Reducing -1,830
ICICI Lombard General Insurance Company Limited Feb 2026 ▼ Reducing -1,040
Sun Pharmaceutical Industries Limited Feb 2026 ▼ Reducing -460
Navin Fluorine International Limited Feb 2026 ▼ Reducing -167
Divi's Laboratories Limited Feb 2026 ▼ Reducing -150
Abbott India Limited Feb 2026 ▼ Reducing -90
Max Healthcare Institute Limited Jan 2026 ▼ Reducing -12,090
Aster DM Quality Care Limited Jan 2026 ▲ Increasing +6,490
Rainbow Childrens Medicare Limited Jan 2026 ▼ Complete exit -6,055
Krishna Institute of Medical Sciences Limited Jan 2026 ▲ Increasing +3,610
Sai Life Sciences Limited Jan 2026 ▲ Increasing +3,000
PB Fintech Limited Jan 2026 ▼ Reducing -2,230
Lenskart Solutions Limited Jan 2026 ▼ Reducing -1,750
ICICI Lombard General Insurance Company Limited Jan 2026 ▼ Reducing -1,430
Dr. Reddy's Laboratories Limited Jan 2026 ▼ Reducing -1,000
Global Health Limited Jan 2026 ▼ Reducing -660
Sun Pharmaceutical Industries Limited Jan 2026 ▼ Reducing -520
Divi's Laboratories Limited Jan 2026 ▼ Reducing -120

Changes compare consecutive month-end disclosures for this portfolio only.